Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group

BACKGROUND: Treatment for pediatric psoriasis is challenging because of the lack of real-world evidence, especially for biological therapies. OBJECTIVES: This study evaluated the efficacy and safety of biologics in children with psoriasis based on real-world evidence. METHODS: Pediatric psoriasis pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yu-Xin, Ye, Li-Ran, Yan, Bing-Xi, Chen, Si-Qi, Cai, Sui-Qing, Man, Xiao-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490006/
https://www.ncbi.nlm.nih.gov/pubmed/36160145
http://dx.doi.org/10.3389/fmed.2022.1009991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490006/
https://www.ncbi.nlm.nih.gov/pubmed/36160145
http://dx.doi.org/10.3389/fmed.2022.1009991

Ejemplares similares